Company Profile

Chemrx Advanced Technologies Inc (AKA: Systems Integration Drug Delivery Company)
Profile last edited on: 10/30/07      CAGE:       UEI:

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
----
First Award
2000
Latest Award
2000
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

9040 S Rita Road Suite 2338
Tucson, AZ 85747
   (520) 663-4001
   bseligm@siddco.com
   www.siddco.com
Location: Single
Congr. District: 02
County: 

Public Profile

Chemrx Advanced Technologies Inc was acquired by Infinity Pharmaceuticals, Inc. Formerly know as as SIDDCO, Chemrx Advanced Technologies Inc ( A subsidiary of Discovery Partners International Inc) the firm is a privately held BioHighTech company developing, integrated new enabling technologies into drug discovery to reduce drug development time and improve success. Enabling technologies include: (i) combinatorial chemistry to rapidly synthesize thousands to millions of new compounds that have potential value as pharmaceuticals, (ii) High Density Miniaturized Screening (HDMS) for testing 100,000Õs of compounds per day, and (iii) Multi-Array Plate Screening (MAPS), a proprietary Ògene-to-screenÓ technology which permits simultaneous screening of many targets. These technologies provide clients novel chemical compounds from which to identify hits, streamlined combinatorial medicinal chemistry optimization of leads, and unique and information rich bioassays that maximize the number of drug discovery screens, minimizing time to start the screening process, and enable efficacy, specificity, and safety to be assessed and optimized simultaneousl

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2000 1 NIH $100,000
Project Title: Maps Array Diagnostic Detection Of Exfoliated Cells

Key People / Management

  Bruce E Seligman -- President

Company News

There are no news available.